Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 11/20 | 0.56 |
| ▸ | PPARD | Q03181 | 9/20 | 0.56 |
| ▸ | LDHA | P00338 | 1/20 | 0.52 |
| ▸ | PPARG | P37231 | 5/20 | 0.49 |
| ▸ | STING1 | Q86WV6 | 2/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.47 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.47 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.47 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12056053 | 0.90 | PPARA (0.59) | PPARAPPARDLDHAPPARGSTING1 | |
| SCHEMBL21944056 | 0.89 | PPARA (0.58) | PPARAPPARDLDHAPPARGSTING1 | |
| SCHEMBL18082680 | 0.82 | LDHA (0.76) | PPARAPPARDLDHAALOX15TUBB1 | |
| SCHEMBL9781691 | 0.82 | LDHA (0.76) | PPARAPPARDLDHAALOX15TUBB1 | |
| SCHEMBL13640498 | 0.81 | GABRA1 (0.50) | PPARAPPARDPPARGALOX15ALOX5 | |
| Hydrazine SCHEMBL1648713 | 0.80 | LDHA (0.71) | PPARAPPARDLDHAALOX15TUBB1 | |
| SCHEMBL26037611 | 0.78 | GABRA1 (0.55) | ALOX5GABRA1GABRB2 | |
| SCHEMBL6938099 | 0.78 | LDHA (0.60) | PPARAPPARDLDHAALOX15TUBB1 | |
| SCHEMBL13956396 | 0.78 | PPARA (0.55) | PPARAPPARDALOX5GABRA1GABRB2 | |
| SCHEMBL10957252 | 0.78 | PPARA (0.52) | PPARAPPARDPPARGALOX5GABRA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120283490-A1 | System, Device and Method for Preparing Tracers and Transferring Materials During Radiosynthesis | SIEMENS MEDICAL SOLUTIONS USA, INC. (US) | 2012-11-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120283490-A1 | System, Device and Method for Preparing Tracers and Transferring Materials During Radiosynthesis | TERT, VHL, REV1 | PPARA 2204/4885PPARD 2846/4885LDHA 2311/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.